Photosensitive Epilepsy and Polycystic Ovary Syndrome as Manifestations of MERRF
Related Experiment Video
Updated: Dec 5, 2025

Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
Published on: September 20, 2024
1Klinik Landstrasse, Vienna, Austria.
Objectives:
Although endocrinologic involvement and epilepsy are frequent features of myoclonic epilepsy with ragged-red fibers (MERRF), polycystic ovary syndrome (PCOS) and photosensitive epilepsy have not been reported. Case Report. A 32-year-old female was diagnosed with MERRF at age 19 y upon presence of the four canonical features and the variant m.8344A > G in MT-TK (tRNA (Lys)) (blood heteroplasmy rate: 50%). She experienced recurrent photosensitive focal and generalised seizures since age 19 y, which could be triggered by flickering light or by looking at small stones, leaves, or dirty snow on the ground. Since the last 42 months, she was seizure-free upon levetiracetam (4000 mg/d), clonazepam (1.5 mg/d), and topiramate (25 mg/d). Additionally, she suffered from secondary amenorrhoea since adolescence. She was married between ages 19 y and 25 y but did not get pregnant. PCOS was diagnosed and treated with desogestrel plus estradiol. Nonetheless, the course was progressive, particularly with regard to ataxia, myocloni, and myopathy.
Conclusions:
The phenotypic spectrum of MERRF is broader than anticipated and may additionally include PCOS and photosensitive epilepsy. PCOS in MERRF may respond to hormone substitution and photosensitive epilepsy to levetiracetam, clonazepam, and topiramate.
Insights
Myoclonic epilepsy with ragged-red fibers (MERRF) can present with polycystic ovary syndrome (PCOS) and photosensitive epilepsy. These MERRF symptoms may respond to hormone therapy and anti-seizure medications, respectively.
Area of Science:
- Mitochondrial Medicine
- Neurology
- Endocrinology
Background:
- Myoclonic epilepsy with ragged-red fibers (MERRF) is a mitochondrial disorder typically characterized by specific neurological and muscular symptoms.
- Endocrinologic dysfunction and epilepsy are common in MERRF, but polycystic ovary syndrome (PCOS) and photosensitive epilepsy have not been previously reported.
Observation:
- A 32-year-old female with MERRF, confirmed by the m.8344A>G mutation in MT-TK, presented with photosensitive focal and generalized seizures since age 19.
- She also experienced secondary amenorrhea and was diagnosed with PCOS, treated with hormone replacement therapy.
- Despite treatment, her MERRF symptoms, including ataxia, myoclonus, and myopathy, showed progressive worsening.
Findings:
- This case report highlights the potential for MERRF to manifest with a broader phenotypic spectrum, including PCOS and photosensitive epilepsy.
- Photosensitive epilepsy in this patient was effectively managed with levetiracetam, clonazepam, and topiramate.
- Polycystic ovary syndrome in the context of MERRF appeared to respond to hormone substitution therapy.
Implications:
- The findings suggest that clinicians should consider PCOS and photosensitive epilepsy in the differential diagnosis of MERRF patients with relevant symptoms.
- This broadens the understanding of MERRF's clinical variability and emphasizes the importance of comprehensive patient evaluation.
- Effective management strategies for these additional MERRF manifestations may involve established treatments for PCOS and epilepsy.
Related Concept Videos
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Photoreceptors and Visual Pathways
Disorders of the Female Reproductive System
Seizures: Classification
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Inborn Errors of Metabolism

